These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18554205)

  • 1. Ablation of atrial fibrillation in the setting of hypertrophic cardiomyopathy.
    Callans DJ
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1015-6. PubMed ID: 18554205
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ; Munger TM; Friedman PA; Asirvatham SJ; Brady PA; Cha YM; Rea RF; Shen WK; Powell BD; Ommen SR; Monahan KH; Haroldson JM; Packer DL
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1009-14. PubMed ID: 18479329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmia recurrence after atrial fibrillation ablation: can magnetic resonance imaging identify gaps in atrial ablation lines?
    Reddy VY; Schmidt EJ; Holmvang G; Fung M
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):434-7. PubMed ID: 18179530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy.
    Chen MS; McCarthy PM; Lever HM; Smedira NG; Lytle BL
    Am J Cardiol; 2004 Feb; 93(3):373-5. PubMed ID: 14759397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors.
    Contreras-Valdes FM; Buxton AE; Josephson ME; Anter E
    J Am Coll Cardiol; 2015 Apr; 65(14):1485-7. PubMed ID: 25857916
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
    Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Another use for radiofrequency energy during an atrial fibrillation ablation procedure.
    Knecht S; Jaïs P; Haïssaguerre M
    Europace; 2007 Dec; 9(12):1142-3. PubMed ID: 17684065
    [No Abstract]   [Full Text] [Related]  

  • 8. Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning).
    Estes NAM; Wong TC
    J Am Heart Assoc; 2021 Feb; 10(3):e019876. PubMed ID: 33459028
    [No Abstract]   [Full Text] [Related]  

  • 9. Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: do not throw in the towel too fast!
    O'Neill L; Duytschaever M; Knecht S
    Europace; 2021 Sep; 23(9):1334-1335. PubMed ID: 33930128
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Agarwal S; Munir MB; Patel H; DeSimone CV; Deshmukh A; Asad ZUA
    Am J Cardiol; 2023 Nov; 207():1-3. PubMed ID: 37717284
    [No Abstract]   [Full Text] [Related]  

  • 11. Focal AF-ablation after pulmonary vein isolation in a patient with hypertrophic cardiomyopathy using cryothermal energy.
    Van Belle Y; Michels M; Jordaens L
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1358-61. PubMed ID: 18811822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation ablation in systolic heart failure patients: a promising tool?
    Schmidt M; Daccarett M; Brachmann J
    Europace; 2010 Jan; 12(1):1-2. PubMed ID: 20008490
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertrophic obstructive cardiomyopathy and septal ablation.
    Steinbis S
    Crit Care Nurse; 2003 Jun; 23(3):47-50. PubMed ID: 12830780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Catheter ablation of atrial fibrillation].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2001; 117(20):1997-9. PubMed ID: 12183912
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful catheter ablation of atrial fibrillation in a patient with dextrocardia.
    Yamada T; McElderry HT; Doppalapudi H; Platonov M; Epstein AE; Plumb VJ; Kay GN
    Europace; 2008 Sep; 10(9):1120-2. PubMed ID: 18565975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation strategies for atrial fibrillation.
    Ghanbari H; Schmidt M; Machado C; Segerson NM; Daccarett M
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1091-101. PubMed ID: 19764862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and hypertrophic cardiomyopathy: More progress needed.
    Chrispin J; Marine JE
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):667-668. PubMed ID: 33428313
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
    Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
    Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
    [No Abstract]   [Full Text] [Related]  

  • 19. Inappropriate therapy from a defibrillator complicating transcoronary ablation of septal hypertrophy in a patient with hypertrophic obstructive cardiomyopathy.
    Shah P; Harris L; Hill A; Schwartz L; Cameron D
    Pacing Clin Electrophysiol; 2004 May; 27(5):677-80. PubMed ID: 15125730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heartbeat: Is atrial fibrillation ablation effective in patients with hypertrophic cardiomyopathy?
    Rahimi K; Otto CM
    Heart; 2016 Oct; 102(19):1511-2. PubMed ID: 27625352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.